Its studies showed that, compared with liraglutide, the new peptide led to greater weight loss in individuals with obesity
A propensity-score matched study presented at the American Society of Hematology Annual Meeting in 2024 analyzed 656,588 patients with type 2 diabetes
Consult your physician about specific medication combinations
Exenatide use was associated with a 72% reduction (OR = 0.28, 95% CI: 0.13-0.59, p = 0.0008), and liraglutide with a 71% reduction (OR = 0.29, 95% CI: 0.19-0.46, p = 0.0001)
Drink enough water Eat your veggies and fruits (especially those rich in vitamin C, like oranges, guavas, and strawberries)
In that trial, 4,286 (24.3%) of patients had heart failure with 1,347 of those patients having heart failure with reduced ejection fraction dwarfing the small numbers studied in the initial trials mentioned previously